atrasentan has been researched along with 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (17-(dimethylaminoethylamino)-17-demethoxygeldanamycin) | Trials (17-(dimethylaminoethylamino)-17-demethoxygeldanamycin) | Recent Studies (post-2010) (17-(dimethylaminoethylamino)-17-demethoxygeldanamycin) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 255 | 9 | 168 |
| Protein | Taxonomy | atrasentan (IC50) | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (IC50) |
|---|---|---|---|
| Lysine-specific demethylase 6B | Homo sapiens (human) | 0.4 | |
| Lysine-specific demethylase 4B | Homo sapiens (human) | 0.7 | |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | 0.1699 | |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | 0.2724 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0036 | |
| Lysine-specific demethylase 5A | Homo sapiens (human) | 0.13 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.043 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.0335 | |
| Lysine-specific demethylase 4C | Homo sapiens (human) | 0.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borel Rinkes, IH; Duyverman, AM; Kranenburg, O; Nijkamp, MW; Soeters, ME; van der Bilt, JD; van Diest, PJ; Witteveen, PO | 1 |
1 other study(ies) available for atrasentan and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
| Article | Year |
|---|---|
Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases.
Topics: Animals; Arginine; Atrasentan; Benzoquinones; Cell Line, Tumor; Colorectal Neoplasms; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lactams, Macrocyclic; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Microcirculation; Necrosis; Neoplasm Transplantation; Pyrrolidines; Reperfusion Injury; Time Factors; Tumor Burden | 2007 |